The Defense Advanced Research Projects Agency (DARPA) has developed specifications for an ultrasound scanner tailored for the battlefield: one that searches for internal bleeding, targets the source, and then increases the beam intensity to coagulate the wound. The agency has tapped Philips Medical Systems to build it.
The Defense Advanced Research Projects Agency (DARPA) has developed specifications for an ultrasound scanner tailored for the battlefield: one that searches for internal bleeding, targets the source, and then increases the beam intensity to coagulate the wound. The agency has tapped Philips Medical Systems to build it.
Rising to the challenge, the Dutch company has assembled a multidisciplinary team of engineers from its ultrasound division in Bothell, WA, experts in acoustic hemostasis at the neighboring University of Washington Applied Physics Laboratory, and researchers from Philips Applied Technologies in Houston, PA, and San Jose, CA.
Together they have begun a four-year project to create a device small enough to fit in soldiers' backpacks and smart enough to find the source of bleeding and stop it, when placed on an arm or leg wound.
"There are many challenges involved in getting from concept to work-in-practice," said Michael Pashley, research department head of ultrasound imaging and therapy for Philips Research North America. "The first is to create a somewhat intelligent system that takes the place of a trained physician, understands the ultrasound data, and automatically determines where the bleeding is. Then, on the side of actually coagulating the blood, there is the challenge of getting sufficient energy to the right place without damaging the surrounding tissue."
The need for such a device is evident, based on the kinds of wounds inflicted on American soldiers in Iraq by improved explosive devices. Body armor leaves arms and legs exposed, leading to debilitating and sometimes life-threatening injuries.
Specifications developed by DARPA call for a cuff-like device that would be applied to the arm or leg of a wounded soldier. An ultrasound transponder built into the cuff would search for and localize the source of bleeding much like an automatic defibrillator finds and analyzes the electrical signals of the fibrillating heart. The cuff would stem the bleeding with a high-intensity, focused ultrasound pulse, buying time to move a soldier to a field hospital where intensive care can be given.
DARPA officials hope the device will not only save soldiers' lives but also reduce the number of limbs lost. Such a device might also be adapted for civilian use.
"Being carried on an ambulance is one possible scenario," Pashley said.
DARPA funds awarded nearly a decade ago stimulated the development of the hand-carried ultrasound units now invigorating the ultrasound marketplace. Receiving some of these early grants were the UW Applied Physics Laboratory and ATL, a premier ultrasound vendor (DI SCAN 3/13/96, ATL begins work on futuristic miniature ultrasound scanner). Before its acquisition by Philips, ATL spun off the business unit charged with developing these scanners into a publicly held company. This company, SonoSite, pioneered handheld ultrasound.
This latest round of DARPA funding may foreshadow the next step in the evolution of ultrasound systems: miniaturized devices designed for specific applications.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting DCIS Upgrade to Invasive Breast Cancer: Can Contrast-Enhanced Ultrasound Have an Impact?
August 21st 2024Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.
FDA Clears AI-Powered Cardiovascular Ultrasound System from Siemens Healthineers
August 13th 2024Offering a variety of AI features for streamlined workflow and enhanced visualization, the Acuson Origin ultrasound system also features the newly FDA-cleared AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.